| dc.identifier.uri | http://hdl.handle.net/1951/59889 | |
| dc.identifier.uri | http://hdl.handle.net/11401/71437 | |
| dc.description.sponsorship | This work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree. | en_US |
| dc.format | Monograph | |
| dc.format.medium | Electronic Resource | en_US |
| dc.language.iso | en_US | |
| dc.publisher | The Graduate School, Stony Brook University: Stony Brook, NY. | |
| dc.type | Dissertation | |
| dcterms.abstract | New drugs with novel mechanisms of action are required to meet the
severe threat to human health posed by the emergence of multidrug and extensively drug
resistant strains of Mycobacterium tuberculosis (M. tuberculosis). The cholesterol
metabolism pathway in M. tuberculosis is a potential source of energy as well as secondary
metabolite production that is important for survival of M. tuberculosis in the host
macrophage. Oxidation and isomerization of 3Β-hydroxysterols to 4-en-3-ones by M.
tuberculosis 3Β-hydroxysteroid dehydrogenase (3Β-HSD) is required for sterol
metabolism, and inhibitors of 3Β-HSD are important for targeting the cholesterol
metabolic pathway. In this work, we evaluated a series of azasteroids for inhibition of
3Β-HSD. Our structure-activity studies indicate that the 6-aza version of cholesterol
is the best and tightest binding competitive inhibitor (Ki = 100 nM) of the steroid substrate
and are consistent with cholesterol being the preferred substrate of M. tuberculosis
3Β-HSD. The intracellular growth (igr) operon is required for in vitro growth using
cholesterol as a sole carbon source. The function of igr operon and its role in cholesterol
metabolism is yet to be established. Here we describe the biosynthetic preparation of
isotopically labeled 13C- [1,7,15,22,26]-cholesterol and employ it as a tool to investigate
the cholesterol-derived metabolite profile of the M. tuberculosis H37Rv Δigr mutant
strain by high resolution LC/MS. Culture supernatants from the Δigr mutant accumulate
a cholesterol-derived metabolite not observed in H37Rv wild type or complemented strains.
Multidimensional NMR and mass spectral analysis revealed the structure of this
cholesterol-derived catabolite to be a late stage metabolic product: methyl
1Β-(2'-propanoate)-3aΑ-H-4Α(3'-propanoic
acid)-7aΑ-methylhexahydro-5-indanone. The computationally annotated functions of the
six genes of the igr operon are a lipid transfer protein (ltp2/Rv3540c), two (R)-specific
enoyl-CoA hydratases (Rv3541c and Rv3542c), two acyl-CoA dehydrogenases (fadE29/Rv3543c and
fadE28/Rv3544c), and a cytochrome P450 (cyp125/Rv3545c). Heterologous expression in E. coli
demonstrated that FadE28 forms a heteromeric complex with FadE29, and that likewise, Rv3542c
forms a heteromeric complex with Rv3541c. Biophysical characterization of each complex
established they form novel Α2Β2 heterotetramers. Using synthetic substrates
analogous to the metabolite identified in M. tuberculosis H37Rv Δigr mutant strain, we
verified the catalytic activity of the purified, recombinant FadE28-FadE29 and
Rv3541c-Rv3542c protein complexes to be dehydrogenation and hydration of the
2'-propanoate-CoA side chain. We conclude the igr operon is required for degradation of
the 2'-propanoate side chain fragment during metabolism of cholesterol by M.
tuberculosis. | |
| dcterms.available | 2013-05-22T17:35:42Z | |
| dcterms.available | 2015-04-24T14:47:34Z | |
| dcterms.contributor | Sch? ? rer, Orlando | en_US |
| dcterms.contributor | Sampson, Nicole S | en_US |
| dcterms.creator | Thomas, Suzanne T. | |
| dcterms.dateAccepted | 2013-05-22T17:35:42Z | |
| dcterms.dateAccepted | 2015-04-24T14:47:34Z | |
| dcterms.dateSubmitted | 2013-05-22T17:35:42Z | |
| dcterms.dateSubmitted | 2015-04-24T14:47:34Z | |
| dcterms.description | Department of
Chemistry | en_US |
| dcterms.extent | 151 pg. | en_US |
| dcterms.format | Application/PDF | en_US |
| dcterms.format | Monograph | |
| dcterms.identifier | http://hdl.handle.net/1951/59889 | |
| dcterms.identifier | Thomas_grad.sunysb_0771E_11070 | en_US |
| dcterms.identifier | http://hdl.handle.net/11401/71437 | |
| dcterms.issued | 2012-08-01 | |
| dcterms.language | en_US | |
| dcterms.provenance | Made available in DSpace on 2013-05-22T17:35:42Z (GMT). No. of bitstreams: 1
Thomas_grad.sunysb_0771E_11070.pdf: 16908050 bytes, checksum: 3a89c1162e8eb93be99bdb58435ae84c (MD5)
Previous issue date: 1 | en |
| dcterms.provenance | Made available in DSpace on 2015-04-24T14:47:34Z (GMT). No. of bitstreams: 3
Thomas_grad.sunysb_0771E_11070.pdf.jpg: 1894 bytes, checksum: a6009c46e6ec8251b348085684cba80d (MD5)
Thomas_grad.sunysb_0771E_11070.pdf.txt: 414167 bytes, checksum: af012ca89002204d465da9b491a96865 (MD5)
Thomas_grad.sunysb_0771E_11070.pdf: 16908050 bytes, checksum: 3a89c1162e8eb93be99bdb58435ae84c (MD5)
Previous issue date: 1 | en |
| dcterms.publisher | The Graduate School, Stony Brook University: Stony Brook, NY. | |
| dcterms.subject | Chemistry | |
| dcterms.subject | acyl-CoA dehydrogenase, cholesterol, enoyl-CoA hydratase, intracellular
growth operon, metabolism, Mycobacterium tuberculosis | |
| dcterms.title | Inhibitors of 3&beta-Hydroxysteroid? Dehydrogenase and Metabolic? and
Enzymatic Characterization of the Cholesterol? ? Metabolizing Intracellular
Growth? Operon? of? <italic>Mycobacterium tuberculosis</italic> | |
| dcterms.type | Dissertation | |
